Regulatory Pre-Clearance, Portfolio Cleanup, and Faster Divestitures Reshape Corporate Development

By DripPublished

The gist

Corporate development is shifting from post-signing execution to upfront regulatory design and continuous portfolio pruning, changing who drives deals and how early they shape them.

This week’s developments

Regulatory Pre-Clearance Becomes Core Deal Design

The EU’s 8 June 2026 FDI Screening Regulation and Germany’s proposed merger-control reforms push cross-border M&A into a pre-clearance discipline. The EU now requires national screening mechanisms with common minimum standards, a 45-day initial review, and ex ante approval for sensitive sectors including semiconductors, quantum, AI, dual-use and defense technologies, critical infrastructure, raw materials, and certain financial entities. It also reaches indirect structures such as EU SPVs controlled by non-EU owners, plus some joint ventures and greenfield entries. Germany is raising turnover thresholds to €750 million worldwide, €75 million for the first domestic threshold, and €20 million for the second, while keeping the €400 million transaction-value test and extending it to targets not yet active in Germany but likely to become active.

For Corporate Development, this means deal execution now starts with regulatory architecture: parallel filings, near-simultaneous submissions, and planning for Phase II or post-closing call-in risk. Buyers need earlier diligence on IP ownership, data rights, ultimate control, and whether non-EU control, state influence, or multi-jurisdictional SPVs can clear. For practitioners, the edge shifts upstream: the people who can triage filing risk, map control fast, and coordinate legal, technical, and diligence work before exclusivity will be the most valuable on the team.

How should we redesign deal workflows for pre-clearance?

If you're an individual contributor

  • Pre-clearance is now part of the job, not a legal afterthought.
  • You need to spot filing risk early and map control, IP, and data issues before exclusivity if you want to stay indispensable.

If you manage a team

  • Your team’s edge shifts from deal support to regulatory triage.
  • Coach people to flag jurisdictional risk fast and coordinate legal, diligence, and technical work in parallel, not sequentially.

Sources

If you lead the organization

  • Your operating model must assume regulatory design before signing.
  • Rebuild team coverage around pre-clearance, multi-jurisdiction filings, and Phase II risk or you’ll lose speed on cross-border deals.

Sources

Portfolio Optimization Becomes a Core Corporate Development Discipline

Feb. 25, 2026, Charles River Laboratories agreed to sell European Discovery Services assets to IQVIA for about $145 million in cash plus up to $10 million in contingent payments, while also divesting its CDMO and Cell Solutions businesses to GI Partners after a strategic review. That followed VAALCO Energy’s Feb. 5 sale of non-core Canadian producing properties for C$35 million, or US$25.6 million, at roughly 2.7x trailing 12-month operational cash flow. Barrick Mining also authorized management to explore a partial IPO carve-out of a new subsidiary holding Nevada Gold Mines, Pueblo Viejo, and Fourmile, and Genuine Parts was reported to be weighing a separation of its industrial parts business from auto parts after settling with Elliott.

These moves point to a clear shift from acquisition-led growth to portfolio optimization as a standing Corporate Development mandate. The language is consistent: simplification, sharper strategic focus, capital redeployment, margin improvement, and balance-sheet efficiency. Barrick’s carve-out review is a direct value-unlocking exercise; Genuine Parts shows how activist pressure can force faster separation decisions.

For Corp Dev teams, the work is moving deeper into portfolio triage, carve-out valuation, and separation planning. Expect more time spent modeling standalone economics, sequencing divestiture paths, and coordinating tax, legal, and operating workstreams that decide whether a business is kept, sold, or split.

How should we reprioritize portfolio pruning and exit pricing capabilities?

If you're an individual contributor

  • Your edge shifts from sourcing deals to pricing exits and carve-outs.
  • Get strong on standalone modeling, separation workstreams, and divestiture logic—those skills will make you harder to replace.

If you manage a team

  • Your team must be as good at selling assets as buying them.
  • Rebalance coaching toward carve-out valuation, tax/legal coordination, and portfolio triage so the team can handle more than M&A origination.

Sources

If you lead the organization

  • Corp Dev is now a portfolio-shaping function, not just a deal engine.
  • Shift talent and budget toward separation planning, activist response, and capital redeployment—or your team will lag the mandate.

Sources

Part of these trends

Stay ahead in Corporate Development (M&A)

Get the weekly Corporate Development (M&A) brief in your inbox — the developments, what they mean by seniority, and what to do next.